Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
© 2021 The Authors..
Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in patients with diabetes mellitus, neutropenia, or treatment with corticosteroids. Both infections have been recognized as secondary complications of COVID-19, especially among critically ill patients. We report the first case of combined probable pulmonary aspergillosis and possible mucormycosis in a male with COVID-19 in the ICU.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
|---|---|
| Enthalten in: |
Medical mycology case reports - 32(2021) vom: 07. Juni, Seite 64-67 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Johnson, Andre K [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Aspergillosis |
|---|
| Anmerkungen: |
Date Revised 20.04.2021 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.mmcr.2021.03.006 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM323972667 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM323972667 | ||
| 003 | DE-627 | ||
| 005 | 20231225185324.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.mmcr.2021.03.006 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1079.xml |
| 035 | |a (DE-627)NLM323972667 | ||
| 035 | |a (NLM)33842203 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Johnson, Andre K |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pulmonary aspergillosis and mucormycosis in a patient with COVID-19 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 20.04.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2021 The Authors. | ||
| 520 | |a Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in patients with diabetes mellitus, neutropenia, or treatment with corticosteroids. Both infections have been recognized as secondary complications of COVID-19, especially among critically ill patients. We report the first case of combined probable pulmonary aspergillosis and possible mucormycosis in a male with COVID-19 in the ICU | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Aspergillosis | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Invasive | |
| 650 | 4 | |a Mucormycosis | |
| 650 | 4 | |a Pulmonary | |
| 700 | 1 | |a Ghazarian, Zeron |e verfasserin |4 aut | |
| 700 | 1 | |a Cendrowski, Kristina D |e verfasserin |4 aut | |
| 700 | 1 | |a Persichino, Jon G |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Medical mycology case reports |d 2012 |g 32(2021) vom: 07. Juni, Seite 64-67 |w (DE-627)NLM233979751 |x 2211-7539 |7 nnns |
| 773 | 1 | 8 | |g volume:32 |g year:2021 |g day:07 |g month:06 |g pages:64-67 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.mmcr.2021.03.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 32 |j 2021 |b 07 |c 06 |h 64-67 | ||